DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Hilton Lac-Leamy

2019年11月04日 (月) 午前 7:00 - 2019年11月04日 (月) 午後 6:45

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canadian Pharmacovigilance and Risk Management Strategies Conference

Session 1: What’s New and What’s Hot: Perspective on Pharmacovigilance and Risk Management, A Global Perspective

Session Chair(s)

Marc  Poitras, PhD, MBA

Marc Poitras, PhD, MBA

Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau, Health Canada, Canada

In this session, representatives from regulatory agencies MHRA, FDA, and Health Canada will discuss the progress of the implementation of new/ongoing national and international initiatives to strengthen pharmacovigilance and risk management activities.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss a global understanding of the challenges faced and the solutions proposed to address them

Speaker(s)

Mick  Foy

Speaker

Mick Foy

Director of Delivery, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Marc  Mes

Speaker

Marc Mes

Director General, Marketed Health Products Directorate, Health Canada, Canada

Robert  Ball, MD, MPH, MSc

Speaker

Robert Ball, MD, MPH, MSc

Deputy Director, Office of Surveillance and Epidemiology, CDER, FDA, United States

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。